🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Integer Holdings Corporation ITGR R2K

Healthcare · Medical Devices · United States
https://www.integer.net

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

READ MORE ›
$89.38
-24.74% 1Y

Market & Price

Market Cap
$3.03B
Current Price
$89.38
High / Low (52W)
$122.97 / $63.32
Beta
0.66

Valuation

Stock P/E
22.18
Industry PE
23.65
Forward P/E
13.13
PEG Ratio
2.41
Book Value
$49.99
Price to Book
1.79
P/S
1.64
EV/EBITDA
12.15
Dividend Yield
-

Profitability & Returns

ROCE
5.09%
ROE
8.58%
ROA
4.23%
Profit Margin
7.64%
Op Margin
8.16%
EPS (Latest Qtr)
$0.48
EPS (TTM)
$4.03

Balance Sheet & Liquidity

Debt/Equity
0.81
Quick Ratio
2.19
Current Ratio
3.75
Debt
$1.38B
Total Assets
$3.41B
Current Assets
$770.10M
Working Capital
$538.06M

Ownership

Promoter Holding
1.53%
Chg in Prom Hold
-
FII / Inst Holding
118.55%
Chg in FII Hold
-0.00%

Financial Snapshot

Enterprise Value
$4.41B
Total Revenue (TTM)
$1.86B
EBITDA
$362.86M
Free Cash Flow
$98.14M
Operating Cash Flow
$189.57M
Shares Outstanding
33.95M
Gross Margin
26.81%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
11.67%
Profit 5Y
15.70%
Revenue (YoY)
0.50%
Earnings (YoY)
-

PROS

  • Compounding revenue at 11.7% over 5 years.
  • Profit CAGR of 15.7% over 5 years.
  • Generates positive free cash flow.

CONS

  • Trading 27.3% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ITGR Integer Holdings Corporation R2K 89.38 22.18 $3.03B - 5.09% 8.58% 11.67% 15.70%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Jan 2016Apr 2016Jul 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Apr 2020Jul 2020Oct 2020Dec 2020Apr 2021Jul 2021Oct 2021Apr 2022Jul 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Apr 2026
Revenue -----266.74M280.92M286.17M302.26M292.43M314.46M305.09M303.03M314.68M314.19M303.59M325.64M328.43M240.12M235.94M268.96M290.47M312.02M305.57M310.91M350.08M342.68M378.79M400.04M396.80M407.80M427.89M--437.39M476.49M467.69M472.06M439.58M439.58M
Cost of Revenue ----------------------------------317.07M347.34M341.53M347.30M329.99M-
Gross Profit 73.14M91.47M96.03M97.91M92.89M82.03M89.17M89.19M93.62M83.53M98.77M91.92M88.44M88.61M96.98M93.39M76.03M96.70M57.86M57.93M73.21M84.49M88.75M81.87M81.47M92.90M86.72M96.67M105.80M104.99M108.27M117.38M--120.32M129.15M126.16M124.76M109.59M109.59M
Operating Expenses ----------------------------------64.19M66.25M60.26M70.21M74.12M-
Operating Income -11.13M29.27M36.86M-26.55M36.06M35.83M-30.04M44.36M41.46M-39.17M49.34M46.48M-44.08M9.19M39.76M-34.61M39.35M33.09M22.50M32.71M29.26M34.17M41.58M48.78M38.70M54.49M--56.13M62.90M65.90M54.55M35.47M31.87M
EBITDA ----------------------------------29.76M85.89M86.79M89.09M63.47M-
Interest Expense ----------------------------------12.92M8.01M7.75M6.77M8.11M-
Pretax Income -----------------------------------13.00M45.60M45.99M46.81M20.35M-
Tax Provision ----------------------------------9.47M8.59M6.31M-1.80M3.85M-
Net Income -24.91M-12.66M-770.00K11.46M7.93M2.95M9.56M19.88M54.70M13.08M23.06M-8.30M19.20M21.67M33.06M30.59M11.04M31.10M389.00K30.34M-21.52M29.43M22.07M11.37M20.84M16.06M13.06M23.97M27.26M20.51M31.25M---22.49M37.01M39.68M48.61M16.51M16.51M
Diluted EPS -0.85-0.41-0.030.370.250.090.300.621.690.400.70-0.260.580.650.850.920.330.940.010.920.470.650.890.660.340.620.480.390.710.810.590.88-0.90-0.661.041.11-0.480.48

Profit & Loss (Annual)

Figures in USD.

Metric Jan 2010Dec 2010Dec 2011Dec 2012Jan 2014Jan 2015Jan 2016Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -------1.08B1.14B1.22B1.26B1.07B-1.33B1.56B1.72B1.85B
Cost of Revenue -------------985.52M1.15B1.26B1.35B
Gross Profit 166.42M173.58M180.35M201.65M219.31M231.40M235.13M337.68M354.01M362.67M355.01M285.71M-345.76M409.89M459.01M500.39M
Operating Expenses -------------217.81M235.14M238.63M261.25M
Operating Income 1.05M68.99M61.70M25.82M61.34M75.65M13.15M92.92M125.65M155.56M157.63M120.61M-127.95M174.75M220.39M239.14M
EBITDA -------------197.93M255.50M310.91M292.39M
Interest Expense -------------37.27M51.27M52.32M36.32M
Pretax Income -------------68.68M105.38M147.56M125.40M
Tax Provision -------------8.93M16.24M26.51M22.57M
Net Income -9.00M33.14M33.12M-4.80M36.27M55.46M-7.59M5.96M66.68M167.96M96.34M77.26M-66.38M90.65M119.90M102.81M
Diluted EPS -0.391.401.40-0.201.432.14-0.290.192.085.152.922.33-1.992.693.362.89

Compounded Sales Growth

5 Years:11.67%
1 Year:0.50%

Compounded Profit Growth

5 Years:15.70%
1 Year:-

Stock Price Performance

1 Year:-24.74%
6 Months:+25.13%
3 Months:+3.11%
1 Month:+6.82%

Balance Sheet (Annual)

Figures in USD.

Metric Jan 2009Jan 2010Dec 2010Dec 2011Dec 2012Jan 2014Jan 2015Jan 2016Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --776.98M881.35M889.88M889.63M955.12M2.98B2.83B2.85B2.33B2.35B2.37B-2.79B2.94B3.08B3.41B
Current Assets --------------558.30M617.67M671.12M770.10M
Cash & Equivalents 22.06M37.86M22.88M36.51M20.28M35.47M76.82M82.48M52.12M44.10M25.57M---24.27M23.67M46.54M17.16M
Inventory --------------208.77M229.10M247.13M253.74M
Receivables --------------224.32M231.28M245.27M346.08M
Total Liabilities --350.15M414.06M409.01M348.65M341.76M2.13B2.11B1.95B1.27B1.20B1.10B-1.38B1.42B1.46B1.66B
Current Liabilities --60.59M94.05M91.76M91.80M108.66M213.84M185.22M209.00M164.57M179.08M156.19M-223.75M220.97M227.17M232.04M
Long Term Debt --220.63M235.95M225.41M197.50M175.36M1.69B1.70B1.58B888.01M777.27M693.76M-907.07M959.92M980.15M1.19B
Total Debt --------------1.01B1.05B1.10B1.31B
Total Equity 374.79M379.72M426.83M467.28M480.86M542.05M613.36M850.62M725.24M893.38M1.06B1.15B1.27B-1.42B1.52B1.62B1.75B
Shares Outstanding --------------33.17M33.33M33.55M35.48M

Cash Flows (Annual)

Figures in USD.

Metric Jan 2010Dec 2010Dec 2011Dec 2012Jan 2014Jan 2015Jan 2016Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 71.77M76.89M89.92M64.83M56.76M81.28M12.48M105.53M149.36M167.30M165.36M181.34M-116.38M180.21M205.21M196.15M
Investing Cash Flow -21.14M-13.92M-80.39M-59.79M-18.28M-35.92M-473.56M-63.30M-47.94M536.67M-58.86M-56.58M--200.42M-163.37M-195.41M-270.73M
Financing Cash Flow -34.51M-78.82M3.69M-21.45M-23.36M-2.38M467.91M-72.15M-111.67M-725.08M-117.93M-88.58M-92.48M-18.01M13.32M43.56M
Capital Expenditure -19.67M-16.14M-22.49M-41.07M-18.86M-24.83M-44.62M-58.63M-47.30M-44.91M-48.20M-46.83M--74.73M-119.94M-105.36M-91.03M
Free Cash Flow 52.09M60.74M67.43M23.76M37.90M56.45M-32.14M46.90M102.06M122.39M117.16M134.51M-41.65M60.27M99.85M105.12M
Net Change in Cash -------------8.44M-1.17M23.11M-31.02M
Share Buybacks --------------0050.01M

Ratios (Annual)

Figures in %.

Metric Jan 2010Dec 2010Dec 2011Dec 2012Jan 2014Jan 2015Jan 2016Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------31.4%31.2%29.8%28.2%26.6%-26.0%26.3%26.7%27.0%
Operating Margin % -------8.6%11.1%12.8%12.5%11.2%-9.6%11.2%12.8%12.9%
Net Margin % -------0.6%5.9%13.8%7.7%7.2%-5.0%5.8%7.0%5.5%
ROE % -2.4%7.8%7.1%-1.0%6.7%9.0%-0.9%0.8%7.5%15.8%8.4%6.1%-4.7%6.0%7.4%5.9%
ROCE % -9.6%7.8%3.2%7.7%8.9%0.5%3.5%4.8%7.2%7.3%5.4%-5.0%6.4%7.7%7.5%

Shareholding Pattern

Insiders
1.53%
Institutions
118.55%
Public Float
120.39%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 15.63% 5.31M $474.24M
2 Vanguard Portfolio Management LLC 6.03% 2.05M $182.96M
3 Invesco Ltd. 5.80% 1.97M $176.00M
4 Vanguard Capital Management LLC 4.53% 1.54M $137.40M
5 Morgan Stanley 4.53% 1.54M $137.58M
6 Dimensional Fund Advisors LP 4.37% 1.48M $132.68M
7 State Street Corporation 4.12% 1.40M $124.98M
8 Alliancebernstein L.P. 3.84% 1.30M $116.50M
9 Irenic Capital Management LP 3.72% 1.26M $112.95M
10 Earnest Partners LLC 3.07% 1.04M $93.06M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ITGR

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks